Protocol schema. The rhIL-22 dimer F-652 was administered weekly for a total of 4 doses in combination with systemic corticosteroids to patients with newly diagnosed GI aGVHD. Patients were monitored for safety, drug PK, clinical endpoints including day-28 aGVHD response rates, and correlative analyses including fecal microbiota composition.